Status:
COMPLETED
Clinical Impact of MI on Inhaled Antibiotic Adherence in Cystic Fibrosis
Lead Sponsor:
Belfast Health and Social Care Trust
Collaborating Sponsors:
Queen's University, Belfast
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Adherence to treatment is a major challenge in cystic fibrosis (CF). Motivational Interviewing (MI) is increasingly used to address this, but its effectiveness is unknown. We investigated the clinical...
Detailed Description
Adherence to treatment is a major challenge in cystic fibrosis (CF). Motivational Interviewing (MI) is increasingly used to address this, but its effectiveness is unknown. We investigated the clinical...
Eligibility Criteria
Inclusion
- Male or female patients with a documented diagnosis of CF aged ≥18 years on the date of informed consent
- Known chronic infection with Pa, as defined by the Leeds criteria
- Has been prescribed inhaled colomycin and/or tobramycin and/or aztreonam for a minimum of 3 months prior to study enrolment
- Able to provide written informed consent
- Able to understand and comply with protocol requirements and instructions
- Has been identified by the physician during routine appointments as having difficulties with adherence to their inhaled therapies
Exclusion
- Patients that do not expectorate sputum spontaneously
- Inability to complete questionnaires
Key Trial Info
Start Date :
October 22 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 17 2017
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04017559
Start Date
October 22 2014
End Date
May 17 2017
Last Update
July 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.